| Literature DB >> 34997857 |
Karl Forsell1,2, Ove Björ3, Helena Eriksson4, Bengt Järvholm5, Ralph Nilsson4, Eva Andersson4.
Abstract
PURPOSE: Lung cancer, mesothelioma and several lifestyle-associated cancer forms have been reported more common in merchant seafarers. However, few studies reflect recent occupational settings and women seafarers are usually too scarce for meaningful analyses. We conducted a study on cancer incidence between 1985 and 2011 in a Swedish cohort consisting of male and female seafarers.Entities:
Keywords: Cancer incidence; Cohort; Follow-up; Lifestyle; Neoplasm (epidemiology); Occupational disease (epidemiology); Occupational exposure; Record linkage; Risk factor; Seafarer; Sweden
Mesh:
Year: 2022 PMID: 34997857 PMCID: PMC9203388 DOI: 10.1007/s00420-021-01828-2
Source DB: PubMed Journal: Int Arch Occup Environ Health ISSN: 0340-0131 Impact factor: 2.851
Characteristics (selected) of the cohort of men and women Swedish seafarers between 1985 and 2011
| Total | Men | Women | ||
|---|---|---|---|---|
| Person-years | Person-years | |||
| Person-years for all seafarers | 1,245,691 | 823,523 | 422,168 | |
| Start < 1985 | 510,228 | 409,402 | 100,827 | |
| Start 1985–1991 | 414,350 | 214,096 | 200,254 | |
| Start > 1992 | 321,113 | 200,025 | 121,087 | |
| Total numbers of seafarers | 75,745 | 48,787 | 26,958 | |
| Positiona | ||||
| Deck | ||||
| Total | 28,211 | 24,915 | 3296 | |
| Officers | 9261 | 8858 | 403 | |
| Ratings | 26,200 | 23,079 | 3121 | |
| Engine | ||||
| Total | 12,202 | 11,924 | 278 | |
| Officers | 5940 | 5861 | 79 | |
| Ratings | 10,761 | 10,502 | 259 | |
| Catering/service | 42,300 | 17,949 | 24,351 | |
| Tankersa | ||||
| Total | 14,596 | 13,197 | 1399 | |
| Deck | 8475 | 8061 | 414 | |
| Vital status 31st Dec 2011 | ||||
| Alive | 64,034 | 40,473 | 23,561 | |
| Dead | 4876 | 4167 | 709 | |
| Emigrated | 6835 | 4147 | 2688 | |
| Age at start of follow-up | ||||
| < 30 years | 48,404 | 28,146 | 20,258 | |
| 30–59 years | 26,240 | 19,748 | 6492 | |
| ≥ 60 years | 1,101 | 893 | 208 | |
| Time first to last sea service until 2011 | ||||
| < 1 year | 17,419 | 9518 | 7901 | |
| 1–5 year | 23,075 | 12,456 | 10,619 | |
| 5–10 years | 10,173 | 6176 | 3997 | |
| ≥ 10 years | 25,078 | 20,637 | 4441 | |
aAnalysis based on “ever” having held such a position (overlap possible)
Standardized Incidence Ratio (SIR) for total cancer and lung cancer in Swedish seafarers 1985–2011 per position (”ever”) and gender
| Men | Women | |||||
|---|---|---|---|---|---|---|
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | |||
| Total cancer | ||||||
| All positions | 3 221 | 1.05 (1.01–1.09) | 938 | 0.83 (0.78–0.89) | ||
| Deck* | ||||||
| Officers | 1 137 | 1.15 (1.08–1.21) | 27 | 1.15 (0.73–1.62) | ||
| Ratings | 1 717 | 1.08 (1.03–1.13) | 51 | 0.73 (0.54–0.93) | ||
| Enginea | ||||||
| Total | 1 066 | 1.07 (1.00–1.13) | 4 | 0.67 (0.17–1.33) | ||
| Officers | 691 | 1.06 (0.98–1.14) | ≤ 3 | (expected 2) | ||
| Ratings | 903 | 1.12 (1.05–1.19) | 4 | 0.72 (0.18–1.45) | ||
| Catering/servicea | 727 | 1.04 (0.96–1.11) | 880 | 0.83 (0.77–0.88) | ||
| Tankers, all positions | 941 | 1.08 (1.01–1.15) | 65 | 0.94 (0.72–1.17) | ||
| Lung cancer | ||||||
| All positions | 341 | 1.51 (1.35–1.67) | 84 | 1.54 (1.23–1.87) | ||
| Decka | ||||||
| Officers | 108 | 1.38 (1.12–1.65) | 4 | 3.07 (0.77–6.14) | ||
| Ratings | 186 | 1.57 (1.35–1.79) | ≤ 3 | expected 3 | ||
| Enginea | ||||||
| Total | 125 | 1.64 (1.36–1.93) | 0 | expected 0 | ||
| Officers | 76 | 1.49 (1.15–1.84) | 0 | expected 0 | ||
| Ratings | 111 | 1.82 (1.49–2.16) | 0 | expected 0 | ||
| Catering/servicea | 74 | 1.58 (1.24–1.95) | 81 | 1.57 (1.24–1.92) | ||
| Tankers, all positions | 121 | 1.87 (1.54–2.21) | 6 | 1.68 (0.56–3.08) | ||
Obs observed cases; CI confidence interval
aAnalysis based on “ever” having held such a position (overlap possible)
Standardized Incidence Ratio (SIR) by specific site for cancer 1985–2011 among Swedish seafarers, men and women
| ICD-7 | Cancer | Men | Women | ||
|---|---|---|---|---|---|
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | ||
| 140 | Lip | 17 | 1.63 (0.86–2.50) | ≤ 3 | |
| ≥ 5 years cumulative sea service | 16 | 1.96 (1.10–2.94) | |||
| 141 | Tongue | 20 | 1.25 (0.75–1.81) | ≤ 3 | |
| 143–148 | Mouth, pharynx | 76 | 1.66 (1.29–2.05) | 4 | 0.56 (0.14–1.12) |
| ≥ 5 years cumulative sea service | 66 | 2.02 (1.56–2.51) | |||
| 150 | Oesophagus | 54 | 1.52 (1.13–1.94) | ||
| ≥ 5 years cumulative sea service | 45 | 1.64 (1.17–2.15) | |||
| 151 | Stomach | 78 | 1.14 (0.89–1.40) | 12 | 0.95 (0.48–1.51) |
| 153 | Colon | 193 | 1.01 (0.87–1.15) | 50 | 0.91 (0.68–1.17) |
| 154 | Rectum | 141 | 1.06 (0.89–1.25) | 26 | 0.87 (0.57–1.20) |
| 155.0 | Liver | 34 | 1.04 (0.70–1.41) | ≤ 3 | |
| 155.1–9 | Gallbladder | 14 | 0.80 (0.40–1.25) | ≤ 3 | |
| 157 | Pancreas | 52 | 0.87 (0.64–1.12) | 15 | 1.00 (0.53–1.53) |
| 160 | Nasal cavity | 6 | 1.07 (0.36–1.95) | ≤ 3 | |
| 161 | Larynx | 44 | 1.98 (1.40–2.57) | 4 | 3.10 (0.78–6.20) |
| ≥ 5 years cumulative sea service | 38 | 2.21 (1.51–2.97) | |||
| 162.1 | Lung | 341 | 1.51 (1.35–1.67) | 84 | 1.54 (1.23–1.87) |
| ≥ 5 years cumulative sea service | 183 | 1.61 (1.43–1.80) | 43 | 1.61 (1.16–2.10) | |
| 162.2 | Pleura (mesothelioma) | 16 | 1.29 (0.73–1.93) | ||
| 170 | Breast | 291 | 0.74 (0.65–0.82) | ||
| 171 | Cervix uteri | 49 | 0.96 (0.71–1.24) | ||
| 172 | Uterus | 27 | 0.58 (0.36–0.81) | ||
| 175 | Ovaries | 46 | 1.02 (0.73–1.32) | ||
| 177 | Prostate | 812 | 0.92 (0.86–0.98) | ||
| 178 | Testis | 77 | 1.02 (0.79–1.26) | ||
| 179 | Male genitals | 10 | 0.90 (0.36–1.54) | ||
| 180 | Kidney | 79 | 0.86 (0.68–1.06) | 18 | 1.10 (0.61–1.65) |
| 181 | Urinary bladder | 218 | 1.17 (1.02–1.33) | 12 | 0.70 (0.35–1.11) |
| ≥ 5 years cumulative sea service | 183 | 1.26 (1.08–1.44) | 8 | 0.91 (0.34–1.58) | |
| 190 | Malignant melanoma | 176 | 1.04 (0.88–1.19) | 75 | 0.90 (0.71–1.10) |
| 191 | Other skin | 177 | 1.12 (0.95–1.29) | 22 | 0.71 (0.42–1.04) |
| 193 | Brain | 107 | 0.95 (0.77–1.13) | 48 | 0.93 (0.68–1.20) |
| 194–195 | Thyroid | 48 | 0.76 (0.55–0.98) | 35 | 0.62 (0.43–0.83) |
| 196 | Bone | 7 | 1.09 (0.31–2.03) | ≤ 3 | |
| 197 | Connective tissue | 24 | 1.00 (0.63–1.42) | 4 | 0.52 (0.13–1.04) |
| 199 | Other | 91 | 1.18 (0.95–1.43) | 20 | 0.78 (0.47–1.13) |
| 200, 202 | Non-Hodgkin’s lymphoma | 108 | 0.93 (0.75–1.11) | 25 | 0.91 (0.58–1.27) |
| 201 | Hodgkin’s disease | 16 | 0.78 (0.44–1.17) | 8 | 0.96 (0.36–1.68) |
| 203 | Multiple myeloma | 32 | 0.82 (0.54–1.13) | 8 | 0.98 (0.37–1.72) |
| 204–209 | Leukaemia | 105 | 1.01 (0.82–1.22) | 18 | 0.65 (0.36–0.98) |
| 140–209 | All sites | 3221 | 1.05 (1.01–1.09) | 938 | 0.83 (0.78–0.89) |
| ≥ 5 years cumulative sea service | 2491 | 1.10 (1.06–1.15) | 357 | 0.82 (0.73–0.90) | |
Obs observed cases; CI confidence interval
Standardized Incidence Ratio (SIR) for all and selected cancers among Swedish seafarers, men and women, applying a 10 years’ latency from start of exposure (first sea service) (n = 54 926); 1985–2011
| ICD-7 | Men | Women | |||
|---|---|---|---|---|---|
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | ||
| All | 2 912 | 1.06 (1.03–1.10) | 741 | 0.84 (0.78–0.90) | |
| 140 | Lip | 17 | 1.79 (0.95–2.74) | ≤ 3 | |
| 143–148 | Mouth and pharynx | 72 | 1.76 (1.37–2.18) | ≤ 3 | |
| 150 | Oesophagus | 51 | 1.57 (1.17–2.00) | ≤ 3 | |
| 161 | Larynx | 42 | 2.08 (1.49–2.73) | ≤ 3 | |
| 162.1 | Lung | 327 | 1.57 (1.41–1.75) | 76 | 1.62 (1.26–2.01) |
| 181 | Urinary bladder | 203 | 1.19 (1.03–1.35) | 12 | 0.82 (0.41–1.30) |
Obs observed cases; CI confidence interval
Standardized Incidence Ratio (SIR) for cancer 1985 to 2011 among all Swedish male merchant seafarers and those ever working on tankers across three calendar periods by first sea service (< 1985, 1985–1991, > 1992)
| All male seafarers | < 1985 | 1985–1991 | > 1992 | Trend | |||
|---|---|---|---|---|---|---|---|
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | Obs | SIR (95% CI) | ||
| All sites of cancer | 2544 | 1.10 (1.06–1.15) | 360 | 0.86 (0.78–0.96) | 317 | 0.93 (0.83–1.03) | < 0.0001 |
| Lung cancer | 300 | 1.65 (1.47–1.83) | 27 | 1.07 (0.68–1.51) | 14 | 0.76 (0.38–1.19) | 0.0014 |
| Urinary bladder cancer | 185 | 1.24 (1.07–1.43) | 18 | 0.84 (0.47–1.26) | 15 | 0.95 (0.51–1.46) | 0.1188 |
| Male tanker seafarers | |||||||
| All sites of cancer | 467 | 1.14 (1.04–1.25) | 375 | 1.06 (0.95–1.17) | 99 | 0.93 (0.75–1.12) | 0.07 |
| Leukaemiaa | 19 | 1.44 (0.84–2.13) | 18 | 1.52 (0.84–2.27) | 4 | 0.99 (0.25–1.99) | < 0.05 |
| Lymphomaa | 16 | 1.07 (0.60–1.60) | 11 | 0.80 (0.36–1.31) | 4 | 0.94 (0.23–1.87) | 0.50 |
Obs observed cases; CI confidence interval
a1985–2011 Leukaemia SIR 1.41, 95% CI 1.00–1.86, Lymphoma SIR 0.94, 95% CI 0.64–1.27